Radiology Imaging

The radiology imaging channel includes technology news related to computed tomography (CT), digital radiography (DR / X-ray), ultrasound, magnetic resonance imaging (MRI), radiographic fluoroscopy (R/F), mammography, angiography, 3-D printing, contrast media injectors, molecular imaging, neurological imaging, pediatric imaging and radiation dose management. 

Konica Minolta Healthcare Americas, Inc. is pleased to announce the appointment of Fumihiko Hayashida as the company’s new President and CEO, effective April 1, 2022. Fumi will succeed David Widmann, who is retiring at the end of the company’s fiscal year on March 31.
News | Radiology Business
Konica Minolta Healthcare Appoints New President and CEO

March 31, 2022 — Konica Minolta Healthcare Americas, Inc. is pleased to announce the appointment of Fumihiko Hayashida ...

Time March 31, 2022
arrow
BUSM researchers have proposed a method of assigned sex estimation that is “population-inclusive” by using 3D volume-rendered computed tomography scans of ancestry skulls to estimate assigned sex at birth
News | Computed Tomography (CT)
Researchers Use Skull CT Scans to Estimate Assigned Gender at Birth

March 31, 2022 — One of the essential roles of the forensic anthropologist is the development of a biological profile ...

Time March 31, 2022
arrow
Aidoc, a leading provider of healthcare AI solutions, announced that it received FDA 510(k) clearance for its triage and notification of pneumothorax on X-ray exams.
News | Artificial Intelligence
Aidoc Expands AI Service to X-ray, Receiving FDA 510(k) Clearance for Pneumothorax

March 31, 2022 — Aidoc, a leading provider of healthcare AI solutions, announced that it received FDA 510(k) clearance ...

Time March 31, 2022
arrow
Images in a 68-year-old woman with a screen-detected ductal carcinoma in situ with an artificial intelligence (AI) score of 10 on the screening mammograms.
News | Breast Imaging
AI Shows Potential in Breast Cancer Screening Programs

March 31, 2022 — A major new study in Radiology shows that artificial intelligence (AI) is a promising tool for breast ...

Time March 31, 2022
arrow
Artificial intelligence (AI) is an effective tool for fracture detection that has potential to aid clinicians in busy emergency departments, according to a study in Radiology.
News | Artificial Intelligence
Artificial Intellegence Helps Radiologists Detect Bone Fractures

March 30, 2022 — Artificial intelligence (AI) is an effective tool for fracture detection that has potential to aid ...

Time March 30, 2022
arrow
Diana Miglioretti, professor at UC Davis Health
News | Mammography
Half of all Women Experience False Positive Mammograms After 10 Years of Annual Screening

March 30, 2022 — A study led by UC Davis Health has found that half of all women will experience at least one false ...

Time March 30, 2022
arrow
Breast density notifications aim to educate women about the risks of high breast density, defined as having more fibroglandular tissue than fatty tissue, as visualized on a mammogram.
News | Breast Density
New Findings Suggest That ‘One Size Does Not Fit All’ with Regard to Breast Density Education

March 30, 2022 — Breast density notifications aim to educate women about the risks of high breast density, defined as ...

Time March 30, 2022
arrow
Serial non-contrast axial chest CTs of three study participants with prior COVID-19 pneumonia.
News | Coronavirus (COVID-19)
Lung Damage May Persist Long After COVID-19 Pneumonia

March 29, 2022 — Some people recovering from COVID-19 pneumonia have CT evidence of damage to their lungs that persists ...

Time March 29, 2022
arrow
“The Fundamental Flaws of the Canadian National Breast Screening Study (CNBSS) Trials: A Scientific Review,” authored by Seely, et al and published on March 29, 2022 in the Journal of Breast Imaging, reinforces criticism directed towards the CNBSS trials.
News | Breast Imaging
First-Hand Accounts in New Paper Cement the Flaws of Decades Old Study

March 29, 2022 — “The Fundamental Flaws of the Canadian National Breast Screening Study (CNBSS) Trials: A Scientific ...

Time March 29, 2022
arrow
GE Healthcare announced the first patient dosed in the Phase III clinical trial for a Positron Emission Tomography (PET) radiopharmaceutical imaging agent which aims to assist in the evaluation of adult patients with suspected Parkinsonian syndromes, support research and improve patient care. 
News | PET Imaging
GE Healthcare Announces First Patient Dosed in Phase III Clinical Trial for New Dopamine Transporter Imaging Radiopharmaceutical

March 29, 2022 — GE Healthcare announced the first patient dosed in the Phase III clinical trial for a Positron Emission ...

Time March 29, 2022
arrow
T2w images with overlays of lesion boundaries, DWI-derived ADC, DCE-derived 𝐾𝑡𝑟𝑎𝑛𝑠, and CDI𝑠 for six patient cases. (a, b) Two patients with csPCa in the PZ. (c, d) Two patients with csPCa in the TZ. (e) A patient with csPCa in the PZ and insPCa in the TZ. (f) A patient with csPCa in the AS and insPCa in the PZ.
News | Magnetic Resonance Imaging (MRI)
MRI Innovation Makes Cancerous Tissue Light Up and Easier to See

March 28, 2022 — A new form of magnetic resonance imaging (MRI) that makes cancerous tissue glow in medical images could ...

Time March 28, 2022
arrow
Representative transvaginal US images of classic lesions; color Doppler blood flow with color bar signifies direction of flow. (A) Transverse color Doppler image of right adnexa depicts an anechoic cyst with no internal elements or Doppler flow, compatible with a simple cyst. (B) Transverse color Doppler image of left adnexa depicts a cystic lesion with retractile clot and no Doppler flow, compatible with a hemorrhagic cyst. (C) Sagittal gray-scale image of left adnexa depicts a cystic lesion with homogeneo
News | Ultrasound Imaging
RSNA: Researchers Use Ultrasound to Predict Ovarian Cancer

March 28, 2022 — The appearance of ovarian lesions on ultrasound is an effective predictor of cancer risk that can help ...

Time March 28, 2022
arrow
Selection of mammographic mediolateral oblique views of breasts with different breast density from women between 51 and 68 years of age.
News | Breast Density
AI Provides Accurate Breast Density Classification

March 28, 2022 — An artificial intelligence (AI) tool can accurately and consistently classify breast density on ...

Time March 28, 2022
arrow
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, supports Advanced Accelerator Applications, a Novartis company, as a long-term supplier for the medical radioisotope component of the newly U.S. Food and Drug Administration (FDA) approved radiotherapeutic, Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treat
News | Prostate Cancer
ITM Provides n.c.a. Lutetium-177 as Long-Term Supplier for Recently Approved Novel Radiotherapeutic in Metastatic Prostate Cancer

March 28, 2022 — ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, supports ...

Time March 28, 2022
arrow
The Abbreviated MR collection is designed to enhance a learner’s competence related to the utility of abbreviated breast MR, how to implement such a program, and the importance of performance metrics.
News | Breast Imaging
SBI Offers Symposium Collection Lecture Series

March 25, 2022 — SBI presents the Symposium Collection Series, a curation of lectures from the Society’s recent annual ...

Time March 25, 2022
arrow
76-Year-Old Patient, Not on Antithrombotic Therapy, Presenting to ED After Ground-Level Fall (Glasgow Coma Scale of 15)
News | Computed Tomography (CT)
Antithrombotic Therapy Unassociated With Intracranial Hemorrhage After Fall

March 25, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), antithrombotic therapy was not linked to ...

Time March 25, 2022
arrow
Proscia, a leader in digital and computational pathology solutions, announced a multi-year OEM agreement with Siemens Healthineers. Under the agreement, Siemens Healthineers will expand its Enterprise Imaging offering towards the global digital pathology market using Proscia’s Concentriq Dx platform.
News | Digital Pathology
Proscia and Siemens Healthineers Ink Agreement to Expand Global Reach of Digital Pathology

March 25, 2022 — Proscia, a leader in digital and computational pathology solutions, announced a multi-year OEM ...

Time March 25, 2022
arrow
Royal Philips, a global leader in health technology, and NHS National Services Scotland, a non-departmental public body that provides advice and services to National Health Service (NHS) Scotland, today revealed the impact of the COVID-19 pandemic on the Scottish Breast Screening Program (SBSP), and the measures taken to deal with the backlog of delayed appointments. 
News | PACS
Philips PACS interoperability Helps Scotland’s National Health Service Deliver Leading Breast Cancer Screening

March 25, 2022 — Royal Philips, a global leader in health technology, and NHS National Services Scotland, a non ...

Time March 25, 2022
arrow
GE Healthcare unveiled a major digital update for Vscan Air, its cutting-edge, wireless handheld pocket-sized ultrasound device that provides crystal clear image quality, whole-body scanning capabilities, and intuitive software - all in the palm of clinicians’ hands. 
News | Ultrasound Imaging
GE Healthcare Advances Vscan Air Handheld Wireless Ultrasound

March 24, 2022 — GE Healthcare unveiled a major digital update for Vscan Air, its cutting-edge, wireless handheld pocket ...

Time March 24, 2022
arrow
With today’s U.S. Food and Drug Administration (FDA) approval of 177Lu-PSMA-617—a radiopharmaceutical therapy to treat metastatic castration-resistant prostate cancer (mCRPC)—the Society of Nuclear Medicine and Molecular Imaging (SNMMI) celebrates one of the greatest success stories in nuclear medicine history.
News | Prostate Cancer
SNMMI Applauds FDA Approval of New Metastatic Prostate Cancer Treatment

March 23, 2022 — With today’s U.S. Food and Drug Administration (FDA) approval of 177Lu-PSMA-617—a radiopharmaceutical ...

Time March 23, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now